The Hyderabad-based agency has began supplying its Covid-19 therapy vaccine to the states based mostly on the allocations obtained by the central authorities. “Bharat Biotech confirms direct provides of COVAXIN to the next state govt’s since 1/5/21, based mostly on the allocations obtained by GoI. Requests have been obtained from different states, & might be processed for distribution based mostly on availability of shares 24×7,” Ella tweeted.
The corporate is supplying vaccines to Andhra Pradesh, Assam, Chhattisgarh, Gujarat, Jammu & Kashmir, Jharkhand, Madhya Pradesh, Odisha, Tamil Nadu, Telangana, Uttar Pradesh and West Bengal.
On April 29, Bharat Biotech introduced a reduce within the worth of ‘Covaxin’ for states to Rs 400 per dose from the sooner Rs 600 per dose.
This adopted widespread criticism of its pricing coverage because it offered Covaxin to the central authorities at Rs 150 per dose.